In vivo experiments confirmed that a 1.38-fold knockdown of TNFα was observed with PLN-TPPS2a-TNFα siRNA compared to the psoriasis group, suggesting that it enhanced the preventive effect of psoriatic plaques. The gene discussed is TNF; the disease is psoriasis.